Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

The company's revenue jumped 77% in Q3 to reach $401.6 million in Q3 2024, alongside a net income of $75.6 million. It now ...

The expanded services help customers receive consultations and medications for erectile dysfunction, men’s hair loss, eyelash growth, motion sickness, and anti-aging skin care.

The Board of each Fund announced today the elevation of independent Director Eileen A. Kamerick to Chair of Board, effective . Ms. Kamerick replaces Jane Trust, the former Chair of the Board of the ...

Amazon announced Prime members can access new upfront pricing for treatment of five common conditions such as erectile ...

Citi analyst Daniel Grosslight has maintained their neutral stance on HIMS stock, giving a Hold rating on November 6. Daniel ...

Health-care companies fell sharply after reports that Donald Trump will pick Robert F. Kennedy Jr. as his nominee for head of Health and Human Services Department.

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.

Shares of vaccine makers fell on reports that President-elect Donald Trump is expected to nominate Robert F. Kennedy Jr., a ...

Walt Disney’s earnings beat Wall Street estimates, Super Micro Computer extends losses, and Cisco posts fiscal first-quarter ...

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will ...

Shares of Hims & Hers (HIMS) are sliding on Thursday after Amazon (AMZN) announced the launch of its Amazon One Medical Pay-per-visit ...